This HTML5 document contains 54 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://dx.doi.org/10.1097/
n8http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q37303839
rdf:type
wikibase:Item
schema:description
مقالة علمية نشرت في يناير 2009 vedecký článok videnskabelig artikel научни чланак vědecký článek artículu científicu espublizáu en 2009 vetenskaplig artikel article scientifique wetenschappelijk artikel scientific article published on January 2009 article científic wissenschaftlicher Artikel artigo científico наукова стаття, опублікована в січні 2009 articolo scientifico bilimsel makale
p:P577
wds:Q37303839-636CC489-101F-4F79-BD77-68D9065857D4
wdt:P577
2009-01-01T00:00:00Z
p:P2093
wds:Q37303839-C19F5F6E-B78C-40A1-9644-C659A2257969 wds:Q37303839-3AD80CA2-0AA8-404F-A01F-76F3B82D976A
wdt:P2093
Jaclyn L Kovach Philip J Rosenfeld
rdfs:label
Bevacizumab (avastin) therapy for idiopathic macular telangiectasia type II. Bevacizumab (avastin) therapy for idiopathic macular telangiectasia type II. Bevacizumab (avastin) therapy for idiopathic macular telangiectasia type II.
skos:prefLabel
Bevacizumab (avastin) therapy for idiopathic macular telangiectasia type II. Bevacizumab (avastin) therapy for idiopathic macular telangiectasia type II. Bevacizumab (avastin) therapy for idiopathic macular telangiectasia type II.
schema:name
Bevacizumab (avastin) therapy for idiopathic macular telangiectasia type II. Bevacizumab (avastin) therapy for idiopathic macular telangiectasia type II. Bevacizumab (avastin) therapy for idiopathic macular telangiectasia type II.
p:P1476
wds:Q37303839-63228607-930D-4BFF-8BE6-06BB9A5F2FC5
wdt:P1476
Bevacizumab (avastin) therapy for idiopathic macular telangiectasia type II.
p:P304
wds:Q37303839-8E4C0C6A-9104-4E95-9D58-22187FAD3BFA
wdt:P304
27-32
p:P31
wds:Q37303839-697F0E94-FE67-49E1-BB1B-2AEAFAF8FAC9
wdt:P31
wd:Q13442814
p:P921
wds:Q37303839-F3CF213E-A7C9-4C6F-8BE8-62CBD813B8DF
wdt:P921
wd:Q413299
p:P698
wds:Q37303839-9DDF6B7B-69AE-4CD4-8909-4C25768427BB
wdtn:P698
n8:18936721
wdt:P698
18936721
p:P1433
wds:Q37303839-C8843A8D-70C4-48F4-A8DB-5653568E73E5
wdt:P1433
wd:Q15753094
p:P433
wds:Q37303839-858D142E-193C-4D8B-BF16-235FEC40592B
p:P478
wds:Q37303839-0D1089CA-DF1B-4F77-89F2-E3CE7F389225
wdt:P433
1
wdt:P478
29
p:P1104
wds:Q37303839-186718EB-0AB6-415E-8CDC-EBB750B2A981
wdt:P1104
6
p:P356
wds:Q37303839-1ADBF6AD-B119-42D7-A7E1-398EB6B4C8FE
wdtn:P356
n11:IAE.0B013E31818BA9DE
wdt:P356
10.1097/IAE.0B013E31818BA9DE